Furthermore, its involvement extends to tumor development and prognosis, where elevated NEAT1 levels correlate with unfavorable outcomes among cancer patients (Taiana et al., 2020[71]; Thankachan et al., 2021[72]; Zhang et al., 2022[94]). This evidence concerns the gene NEAT1 and cancer.